We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current GLSI market cap is 160.63M. The company's latest EPS is USD -0.6765 and P/E is -18.00.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -2.5M | -2.84M | -2.54M | -2.66M | -2.73M |
| Net Income | -2.39M | -2.75M | -2.47M | -2.61M | -2.67M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 |
| Operating Income | -1.86M | -4.6M | -8.04M | -9.33M |
| Net Income | -1.86M | -4.57M | -7.83M | -8.89M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Total Assets | 9.15M | 7M | 5.51M | 7.23M | 5.83M |
| Total Liabilities | 297k | 295k | 389k | 1.35M | 842k |
| Total Equity | 8.85M | 6.7M | 5.12M | 5.88M | 4.98M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 28.68M | 27.22M | 13.48M | 7M |
| Total Liabilities | 1.05M | 385k | 263k | 295k |
| Total Equity | 27.63M | 26.83M | 13.21M | 6.7M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Operating | -4.32M | -6.48M | -1.78M | -2.83M | -5.41M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | N/A | N/A | 299k | 3.07M | 4.25M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -1.15M | -4.29M | -6.2M | -6.48M |
| Investing | N/A | N/A | N/A | N/A |
| Financing | 29.81M | 2.84M | -7.54M | N/A |
| Market Cap | 160.63M |
| Price to Earnings Ratio | -18.00 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 22.91 |
| Price to Book Ratio | 23.9 |
| Dividend Yield | - |
| Shares Outstanding | 13.14M |
| Average Volume (1 week) | 16.15k |
| Average Volume (1 Month) | 20.08k |
| 52 Week Change | -1.69% |
| 52 Week High | 21.44 |
| 52 Week Low | 10.52 |
| Spread (Intraday) | 2.78 (19.17%) |
| Company Name | Greenwich LifeSciences Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.greenwichlifesciences.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
